Logo image of ALIMO.PA

GROUPIMO (ALIMO.PA) Stock Fundamental Analysis

EPA:ALIMO - Euronext Paris - Matif - FR0014000RP6 - Common Stock - Currency: EUR

0.21  -0.16 (-43.24%)

Fundamental Rating

3

Overall ALIMO gets a fundamental rating of 3 out of 10. We evaluated ALIMO against 69 industry peers in the Real Estate Management & Development industry. No worries on liquidiy or solvency for ALIMO as it has an excellent financial health rating, but there are worries on the profitability. ALIMO does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year ALIMO has reported negative net income.
Of the past 5 years ALIMO 4 years were profitable.
ALIMO had a negative operating cash flow in each of the past 5 years.
ALIMO.PA Yearly Net Income VS EBIT VS OCF VS FCFALIMO.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2023 0 200K -200K 400K 600K

1.2 Ratios

With a Return On Assets value of -11.54%, ALIMO is not doing good in the industry: 82.43% of the companies in the same industry are doing better.
With a Return On Equity value of -19.18%, ALIMO is not doing good in the industry: 71.62% of the companies in the same industry are doing better.
ALIMO has a Return On Invested Capital of 0.47%. This is comparable to the rest of the industry: ALIMO outperforms 44.59% of its industry peers.
Industry RankSector Rank
ROA -11.54%
ROE -19.18%
ROIC 0.47%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALIMO.PA Yearly ROA, ROE, ROICALIMO.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2023 0 100 200

1.3 Margins

ALIMO's Operating Margin of 2.35% is in line compared to the rest of the industry. ALIMO outperforms 45.95% of its industry peers.
ALIMO's Operating Margin has improved in the last couple of years.
ALIMO's Gross Margin of 43.53% is in line compared to the rest of the industry. ALIMO outperforms 48.65% of its industry peers.
In the last couple of years the Gross Margin of ALIMO has grown nicely.
Industry RankSector Rank
OM 2.35%
PM (TTM) N/A
GM 43.53%
OM growth 3Y-23.29%
OM growth 5Y42.6%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.69%
GM growth 5Y6.77%
ALIMO.PA Yearly Profit, Operating, Gross MarginsALIMO.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2023 0 20 -20 40 60

More info and screens

7

2. Health

2.1 Basic Checks

The number of shares outstanding for ALIMO has been increased compared to 5 years ago.
ALIMO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ALIMO.PA Yearly Shares OutstandingALIMO.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2023 200K 400K 600K 800K 1M
ALIMO.PA Yearly Total Debt VS Total AssetsALIMO.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2023 1M 2M 3M 4M

2.2 Solvency

Based on the Altman-Z score of 1.22, we must say that ALIMO is in the distress zone and has some risk of bankruptcy.
ALIMO's Altman-Z score of 1.22 is fine compared to the rest of the industry. ALIMO outperforms 60.81% of its industry peers.
There is no outstanding debt for ALIMO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 1.22
ROIC/WACCN/A
WACCN/A
ALIMO.PA Yearly LT Debt VS Equity VS FCFALIMO.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2023 0 1M 2M

2.3 Liquidity

ALIMO has a Current Ratio of 3.56. This indicates that ALIMO is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 3.56, ALIMO is in the better half of the industry, outperforming 79.73% of the companies in the same industry.
ALIMO has a Quick Ratio of 3.56. This indicates that ALIMO is financially healthy and has no problem in meeting its short term obligations.
ALIMO's Quick ratio of 3.56 is amongst the best of the industry. ALIMO outperforms 82.43% of its industry peers.
Industry RankSector Rank
Current Ratio 3.56
Quick Ratio 3.56
ALIMO.PA Yearly Current Assets VS Current LiabilitesALIMO.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2023 500K 1M 1.5M 2M 2.5M

More info and screens

1

3. Growth

3.1 Past

ALIMO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1700.00%.
Looking at the last year, ALIMO shows a very negative growth in Revenue. The Revenue has decreased by -27.35% in the last year.
The Revenue has been growing slightly by 5.33% on average over the past years.
EPS 1Y (TTM)-1700%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-133.33%
Revenue 1Y (TTM)-27.35%
Revenue growth 3Y2.77%
Revenue growth 5Y5.33%
Sales Q2Q%-46.67%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALIMO.PA Yearly Revenue VS EstimatesALIMO.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2023 200K 400K 600K 800K 1M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALIMO. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALIMO.PA Price Earnings VS Forward Price EarningsALIMO.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALIMO.PA Per share dataALIMO.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ALIMO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GROUPIMO

EPA:ALIMO (7/23/2025, 7:00:00 PM)

0.21

-0.16 (-43.24%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap279.30K
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.33
P/FCF N/A
P/OCF N/A
P/B 0.13
P/tB 0.13
EV/EBITDA N/A
EPS(TTM)-0.32
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.64
BVpS1.65
TBVpS1.62
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.54%
ROE -19.18%
ROCE 0.64%
ROIC 0.47%
ROICexc 0.47%
ROICexgc 0.48%
OM 2.35%
PM (TTM) N/A
GM 43.53%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-17.9%
ROICexcg growth 5Y47.15%
ROICexc growth 3Y-16.77%
ROICexc growth 5Y47.04%
OM growth 3Y-23.29%
OM growth 5Y42.6%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.69%
GM growth 5Y6.77%
F-ScoreN/A
Asset Turnover0.23
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.56
Quick Ratio 3.56
Altman-Z 1.22
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1700%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-133.33%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-27.35%
Revenue growth 3Y2.77%
Revenue growth 5Y5.33%
Sales Q2Q%-46.67%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y133.33%
EBIT growth 3Y-21.16%
EBIT growth 5Y50.2%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A